Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cibinetide for Sale > High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments
High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments buy - large image1
High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments buy - image1
High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments buy - image2
High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments buy - image3
High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments buy - image4
High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments buy - image5
High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments buy - image6

High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments

TDS 24 Inquiries

Unit Price:

$89-107/UNIT EXW

Get Latest Price
CAS No.:

1208243-50-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

海南

Brand:

SDR

Packaging:

Bottled

Price valid (until):

2027-01-27

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Introduction  


    Items Specifications
    Packaging method Bottled
    Purity 99%
    Product abbreviation RA
    Dosage 40mg*10vials
    Ara‑290 is a synthetic peptide compound targeting the erythropoietin receptor, designed solely for pre‑clinical laboratory research and must not be applied to human subjects.
    In existing pre‑clinical research, Ara‑290 is studied for its ability to modulate related receptor signaling pathways. Research work focuses on observing its biological activities linked to tissue repair and inflammatory response regulation in animal models. Researchers carry out experimental tests to evaluate its effects on signal transduction and explore its potential research value in relevant pre‑clinical model investigations.
    This peptide is provided in powder form for laboratory solution preparation. When stored under recommended conditions, it retains stable physicochemical properties to support reproducible lab tests. All experimental manipulation of Ara‑290 should be performed by trained laboratory staff in accordance with standard lab operating protocols. This product is not a pharmaceutical agent, dietary supplement or cosmetic raw material, and any human‑related application is strictly forbidden.


      Company Profile


    We are a high-tech enterprise dedicated to the research and development of innovative peptide compounds, customized synthesis and supply of scientific research raw materials. We are deeply involved in the fields of peptide chemical synthesis, purification processes and quality analysis, providing high-quality peptide research raw materials and technical support services to domestic and foreign university laboratories, pharmaceutical research institutions and CRO enterprises.
    The company has gathered professional technical teams specializing in peptide synthesis, analysis and testing, and process development. It has established a complete peptide synthesis laboratory, purification platform and quality control testing system, and possesses the capacity for large-scale preparation of long-chain peptides, modified peptides and novel target peptides. It can provide integrated technical support including solid-phase synthesis, liquid-phase synthesis, chromatographic purification, structural characterization and stability research.
    The core scientific research raw material product line covers GLP-1-related target peptides and various innovative active peptide intermediates, among which Retatrutide (LY3437943) is a scientific research grade peptide raw material. All products are for in vitro scientific research and experimental use only. They must not be used for human trials, clinical drug administration, medical aesthetics or any diagnostic or therapeutic purposes.
    The company has established a standardized quality control process. Each batch of raw materials is accompanied by HPLC purity testing and MS mass spectrometry structure verification reports, strictly controlling key indicators such as purity, impurities, and moisture. We can provide services such as repackaging in different specifications, customized synthesis, and process optimization, supporting the experimental needs of research institutions for the early-stage pharmacological research and mechanism exploration of new drug targets.
    Since its establishment, the enterprise has adhered to the concept of compliant operation, strictly abided by relevant laws and regulations on pharmaceutical research and development, and established long-term and stable cooperation with many domestic universities and drug research and development laboratories. With stable product quality, efficient delivery capabilities and professional technical consulting services, we support the basic research of innovative metabolic target drugs and continuously provide reliable raw material support for global peptide basic scientific research.


    Business philosophy


    Focus on the innovative research and development of peptides, strictly adhere to the boundaries of scientific research and application, prioritize quality, and achieve win-win results through integrity

    Contact information





    Email: 1060575270@qq.com

    W hatsapp:+852 5976 3637


      Product display 


    Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 1 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 2 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 3 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 4 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 5 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 6 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 7 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 8 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 9 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 10  Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 11 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 12 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 13 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 14 Shop Ara-290 Peptide Raw Material Stable Batch Consistency for Research Projects-Detailed Image 15


    ECHEMI Editorial Reference
    Cibinetide, also known as ARA-290, is a synthetic 11-mer peptide that binds the tissue-protective receptor. ARA290 inhibits high glucose-induced apoptosis of NRK-52E cells. Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation. Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain. ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception.
    Research & Reference Note

    High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Certificates
    • High Stability Ara-290 Peptide Powder Rigorous QC for Lab Experiments Certificates 1 TDS

    Basic Info
    Product Name:

    Cibinetide

    Other Name:

    ARA-290 (Cibinetide);ARA290, >98%;ARA290,Cibinetide, >98%;ARA290;WZTIQQBMSJTRBR-MUZUOSMHSA-N;ara290/Poziotinib;L-Serine, 5-oxo-L-prolyl-L-α-glutamyl-L-glutaminyl-L-leucyl-L-α-glutamyl-L-arginyl-L-alanyl-L-leucyl-L-asparaginyl-L-seryl-;ARA-290(Cibinetide) acetate

    CAS No.:

    1208243-50-8

    Molecular Formula:

    C51H84N16O21

    InChIKeys:

    WZTIQQBMSJTRBR-WYKNNRPVSA-N

    Molecular Weight:

    1257.31

    EC Number:

    200-001-8

    Color/Form:

    White to off-white

    Characteristics
    Density:

    1.56±0.1 g/cm3(Predicted)

    PKA:

    2.90±0.10(Predicted)

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides,Semagiutide,Retatrutide,GHK-CU,MOTS-c,Semax

    Location:

    Units 1503-14, 15th Floor, New HNA Building, No. 7 Guoxing Avenue, Lantian Subdistrict, Meilan District, Haikou City, Hainan Province

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    101-200

    Year of Establishment:

    2025

  • Inquiry History
    24 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Factory Supply 99% Purity Ara 290 Peptides Raw Lyophilized Powder CAS 1208243-50-8

    1 G Oct 29, 2023
    United States

    Ara 290

    100 MG Aug 4, 2026
    United States

    ARA-290 10mg

    100 PCS Apr 17, 2026
    United States

    ARA-290

    10 MT May 10, 2024
    Denmark

    Cibinetide

    5 G Feb 11, 2024
    Lithuania

    ARA 290

    10  Nov 28, 2023
    United States

    ARA-290

    15 MG Aug 3, 2026
    United States

    ARA 290

    1 G Apr 13, 2026
    United States

    ARA-290 Peptide

    1 G Feb 6, 2026
    United States

    ARA-290

    10 PCS Nov 15, 2025
    Thailand

    Cibinetide

    200 KG May 10, 2025
    Lithuania

    ARA 290

    60  Nov 28, 2023
    Philippines

    I am looking for Ara 290 100 vials

    30 MT Aug 5, 2026
    United States

    Ara-290

    20 MG Jul 20, 2026
    United States

    ARA 290

    1 KG Jun 15, 2026
    Belgium

    ARA290

    1 KG May 20, 2026
    United States

    Reta

    60  May 4, 2026
    United States

    ARA-290 Lyophilized

    800 MG Apr 17, 2026
    United States

    Ara290

    1 G Apr 17, 2026
    Nigeria

    Snap 8

    100 PCS Apr 10, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.